Cns Pharmaceuticals Stock Price Prediction
| CNSP Stock | USD 0.22 0.02 10.00% |
Oversold Vs Overbought
33
Oversold | Overbought |
Cns Pharmaceuticals stock price prediction is an act of determining the future value of Cns Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cns Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cns Pharmaceuticals and does not consider all of the tangible or intangible factors available from Cns Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Cns Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Cns Pharmaceuticals' stock price prediction:Wall Street Target Price 10 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cns Pharmaceuticals based on different types of headlines from major news networks to social media. The Cns stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cns Pharmaceuticals over a specific investment horizon. Using Cns Pharmaceuticals hype-based prediction, you can estimate the value of Cns Pharmaceuticals from the perspective of Cns Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Cns Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cns Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Cns because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cns Pharmaceuticals after-hype prediction price | USD 0.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cns |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cns Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cns Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Cns Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cns Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cns Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cns Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Cns Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cns Pharmaceuticals' historical news coverage. Cns Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 6.73, respectively. We have considered Cns Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cns Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Cns Pharmaceuticals is based on 3 months time horizon.
Cns Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cns Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cns Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cns Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 6.51 | 0.00 | 0.00 | 7 Events / Month | 3 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.22 | 0.22 | 0.00 |
|
Cns Pharmaceuticals Hype Timeline
Cns Pharmaceuticals is currently traded for 0.22. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cns is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Cns Pharmaceuticals is about 1332.46%, with the expected price after the next announcement by competition of 0.22. The company recorded a loss per share of 10.0. Cns Pharmaceuticals had not issued any dividends in recent years. The entity had 1:30 split on the 29th of November 2022. Given the investment horizon of 90 days the next projected press release will be in about 7 days. Check out Cns Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Cns Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Cns Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Cns Pharmaceuticals' future price movements. Getting to know how Cns Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cns Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMGN | Amgen Inc | 2.07 | 9 per month | 0.00 | (0.18) | 1.68 | (2.31) | 9.67 | |
| FHAGX | Fidelity Freedom Blend | 0.00 | 0 per month | 0.29 | (0.27) | 0.42 | (0.52) | 1.45 | |
| RIDGX | Income Fund Of | 0.00 | 0 per month | 0.45 | (0.08) | 0.76 | (0.78) | 2.55 | |
| HPQ | HP Inc | (0.19) | 8 per month | 0.00 | (0.11) | 1.81 | (2.39) | 7.21 | |
| CVX | Chevron Corp | 1.25 | 7 per month | 0.77 | 0.13 | 1.54 | (1.79) | 5.97 | |
| AL | Air Lease | (0.29) | 10 per month | 1.35 | 0.15 | 2.61 | (2.03) | 7.30 | |
| WMT | Walmart | 0.58 | 8 per month | 0.47 | 0.11 | 1.46 | (1.23) | 4.98 |
Cns Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Cns price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cns using various technical indicators. When you analyze Cns charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cns Pharmaceuticals Predictive Indicators
The successful prediction of Cns Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cns Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cns Pharmaceuticals based on analysis of Cns Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cns Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cns Pharmaceuticals's related companies. Story Coverage note for Cns Pharmaceuticals
The number of cover stories for Cns Pharmaceuticals depends on current market conditions and Cns Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cns Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cns Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Cns Pharmaceuticals Short Properties
Cns Pharmaceuticals' future price predictability will typically decrease when Cns Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cns Pharmaceuticals often depends not only on the future outlook of the potential Cns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.8 M | |
| Cash And Short Term Investments | 548.7 K |
Check out Cns Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Cns Stock, please use our How to Invest in Cns Pharmaceuticals guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Cns Stock analysis
When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Cns Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cns Pharmaceuticals. If investors know Cns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.00) | Return On Assets (1.60) | Return On Equity (10.19) |
The market value of Cns Pharmaceuticals is measured differently than its book value, which is the value of Cns that is recorded on the company's balance sheet. Investors also form their own opinion of Cns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.